STROBE-AMS: recommendations to optimise reporting of epidemiological studies on antimicrobial resistance and informing improvement in antimicrobial stewardship

BMJ Open
Evelina TacconelliBarry Cookson

Abstract

To explore the accuracy of application of the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) tool in epidemiological studies focused on the evaluation of the role of antibiotics in selecting resistance, and to derive and test an extension of STROBE to improve the suitability of the tool in evaluating the quality of reporting in these area. A three-step study was performed. First, a systematic review of the literature analysing the association between antimicrobial exposure and acquisition of methicillin-resistant Staphylococcus aureus and/or multidrug-resistant Acinetobacter baumannii was performed. Second, articles were reviewed according to the STROBE checklist for epidemiological studies. Third, a set of potential new items focused on antimicrobial-resistance quality indicators was derived through an expert two-round RAND-modified Delphi procedure and tested on the articles selected through the literature review. The literature search identified 78 studies. Overall, the quality of reporting appeared to be poor in most areas. Five STROBE items, comprising statistical analysis and study objectives, were satisfactory in <25% of the studies. Informative abstract, reporting of bias, control of confo...Continue Reading

References

Jan 1, 1994·Journal of Advanced Nursing·P L Williams, C Webb
Apr 17, 2001·Annals of Internal Medicine·D G AltmanUNKNOWN CONSORT GROUP (Consolidated Standards of Reporting Trials)
Dec 19, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Timothy H DellitUNKNOWN Society for Healthcare Epidemiology of America
Oct 19, 2007·PLoS Medicine·Jan P VandenbrouckeUNKNOWN STROBE Initiative
Jul 23, 2008·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Anthony D Harris, Jessina C McGregor
Apr 28, 2009·Infectious Disease Clinics of North America·Evelina Tacconelli, Maria A Cataldo
Feb 23, 2010·International Journal of Surgery·David MoherUNKNOWN PRISMA Group
Jul 7, 2012·Current Opinion in Infectious Diseases·Patrice Savard, Trish M Perl
Sep 11, 2012·Antimicrobial Resistance and Infection Control·Vincent JarlierUNKNOWN Participants of the 3rd World Healthcare-Associated Infections Forum
Jun 20, 2014·Current Opinion in Infectious Diseases·Pranita D TammaElizabeth Dodds Ashley
Sep 5, 2014·Current Opinion in Critical Care·Ignacio Martín-LoechesJordi Vallés
May 2, 2015·Frontiers in Microbiology·Jan-Willem H DikMaarten J Postma
May 6, 2015·Critical Care : the Official Journal of the Critical Care Forum·Nazaret Cobos-TriguerosJosé Antonio Martínez

❮ Previous
Next ❯

Citations

Apr 15, 2016·Expert Review of Anti-infective Therapy·Jan-Willem H DikAlexander W Friedrich
May 12, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Moi Lin LingGilbert Madriaga
Sep 15, 2016·The Journal of Antimicrobial Chemotherapy·Oren ZusmanMical Paul
Jun 3, 2017·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M E A de KrakerS Harbarth
Sep 30, 2017·The Journal of Antimicrobial Chemotherapy·Madalina TomaBruce Guthrie
Jul 28, 2018·Epidemiology·Melissa K SharpDouglas G Altman
Feb 6, 2018·British Journal of Clinical Pharmacology·Patricia McGettiganAllyson Pollock
Oct 11, 2017·Journal of Infection Prevention·Sheldon Stone, Barry Cookson
Oct 31, 2019·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Andrew M MorrisPranita D Tamma
Jan 19, 2019·The Cochrane Database of Systematic Reviews·Malene Plejdrup HansenChris B Del Mar
Nov 16, 2019·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Matthew H GreeneGeorge E Nelson
Jun 11, 2020·Intensive Care Medicine·Liesbet De BusUNKNOWN DIANA study group
Mar 30, 2017·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Claudia Delgado-CorcoranPhillip T Burch
Dec 26, 2017·Global Health, Epidemiology and Genomics·S AllcockM E Török
May 28, 2020·The European Respiratory Journal·Cristina Ardura-GarciaClaudia E Kuehni
Jan 31, 2021·Infectious Diseases and Therapy·Tali ShafatLior Nesher
Dec 16, 2020·BMC Medical Informatics and Decision Making·Hansi ZhangJiang Bian
Mar 22, 2021·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Erika SilvestroCarlo Scolfaro
Jan 15, 2020·Thérapie·Marie-Cécile PloyUNKNOWN et les participants à la table ronde Recherche translationnelle des Ateliers de Giens XXXV
Oct 2, 2021·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Nina ZhuAlison Holmes

❮ Previous
Next ❯

Software Mentioned

STROBE
STATA
AMS
STROBE for STROBE - AMS

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.